EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

LL‐37 Inhibits TMPRSS2 ‐Mediated S2 ' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants

Zhenfei Bi, Wenyan Ren iD, Hao Zeng, Yuanyuan Zhou, Jian Liu, Zimin Chen, Xindan Zhang, Xuemei He, Guangwen Lu, Yuquan Wei, Xiawei Wei iD

Cell Proliferation · 2025

DOI: 10.1111/cpr.70060 ↗

At a glance

Journal article in Cell Proliferation, 2025. Written by Zhenfei Bi and 10 co-authors. Institution: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China…. Major MEDLINE topics: Serine Endopeptidases, SARS-CoV-2, Cathelicidins, Spike Glycoprotein, Coronavirus. Cited 1 times so far (Crossref); 79 references. The full text is freely available (open access, CC BY 4.0). Funded by: The National Science Foundation for Excellent Young Scholars, National Natural Science Foundation Regional Innovation and Development, China Postdoctoral Science Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Continual evolution of SARS‐CoV‐2 spike drives the emergence of Omicron variants that show increased spreading and immune evasion. Understanding how the variants orientate themselves towards host immune defence is crucial for controlling future pandemics. Herein, we demonstrate that human cathelicidin LL‐37, a crucial component of innate immunity, predominantly binds to the S2 subunit of SARS‐CoV‐2 spike protein, occupying sites where TMPRSS2 typically binds. This binding impedes TMPRSS2‐mediated priming at site S2' and subsequent membrane fusion processes. The mutation N764K within S2 subunit of Omicron variants reduces affinity for LL‐37 significantly, thereby diminishing binding capacity and inhibitory effects on membrane fusion. Moreover, the early humoral immune response enhanced by LL‐37 is observed in mice against SARS‐CoV‐2 spike but not Omicron BA.4/5 spike. These findings reveal the mechanism underlying interactions amongst LL‐37, TMPRSS2 and SARS‐CoV‐2 and VOCs, and highlight the distinct mutation for Omicron variants to evade the fusion activity inhibition by host innate immunity.

Subjects

MeSH terms (MEDLINE)

Serine EndopeptidasesSARS-CoV-2CathelicidinsSpike Glycoprotein, CoronavirusCOVID-19Antimicrobial Cationic PeptidesHumansAnimalsMiceMutationImmunity, InnateHEK293 CellsImmune EvasionProtein Binding

Author keywords

TMPRSS2LL‐37SARS‐CoV‐2 infectionomicron variantsspike protein

Substances

Serine EndopeptidasesCathelicidinsTMPRSS2 protein, humanSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antimicrobial Cationic Peptides

Authors and institutions

  • Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Hepatobiliary Surgery, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Science, Shenzhen, China.

ORCID profiles: Wenyan Ren, Xiawei Wei

Funding

  • The National Science Foundation for Excellent Young Scholars
  • National Natural Science Foundation Regional Innovation and Development
  • China Postdoctoral Science Foundation
  • Sichuan Provincial Natural Science Foundation for Young Scholars

Cite

APA

Bi, Z., Ren, W., Zeng, H., Zhou, Y., Liu, J., Chen, Z., Zhang, X., He, X., Lu, G., Wei, Y., & Wei, X. (2025). LL‐37 Inhibits TMPRSS2 ‐Mediated S2 ' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants. Cell Proliferation. https://doi.org/10.1111/cpr.70060

Vancouver

Bi Z, Ren W, Zeng H, Zhou Y, Liu J, Chen Z, et al. LL‐37 Inhibits TMPRSS2 ‐Mediated S2 ' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants. Cell Proliferation. 2025. doi:10.1111/cpr.70060

BibTeX
@article{Bi2025,
  author = {Bi, Zhenfei and Ren, Wenyan and Zeng, Hao and Zhou, Yuanyuan and Liu, Jian and Chen, Zimin and Zhang, Xindan and He, Xuemei and Lu, Guangwen and Wei, Yuquan and Wei, Xiawei},
  title = {LL‐37 Inhibits TMPRSS2 ‐Mediated S2 ' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants},
  journal = {Cell Proliferation},
  year = {2025},
  doi = {10.1111/cpr.70060}
}
Start for free →